Target intelligence / Profile preview

Prothymosin alpha pseudogene 15 (PTMAP15)

Target: PTMAP15
Molecular classification: Other, Pseudogene

Overview

Prothymosin alpha pseudogene 15 (PTMAP15) is a processed pseudogene in the human genome, part of the prothymosin alpha gene family. Unlike the functional prothymosin alpha gene (PTMA), pseudogenes such as PTMAP15 do not encode a functional protein and are not considered active therapeutic targets. The PTMA gene family consists of one functional gene and several processed pseudogenes, including PTMAP15, which lack protein-coding function and have no direct disease association or known therapeutic relevance.

Other names: prothymosin α pseudogene 15PTMAP15

Beyond the preview

Go deeper on Prothymosin alpha pseudogene 15 (PTMAP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prothymosin alpha pseudogene 15 (PTMAP15).

Explore the full profile